Percutaneously injectable fetal pacemaker: Electrodes, mechanical design and implantation

We are developing a self-contained cardiac pacemaker with a small, cylindrical shape (~3×20mm) that permits it to be implanted percutaneously into a fetus to treat complete heart block and consequent hydrops fetalis, which is otherwise fatal. The device uses off-the-shelf components including a rechargeable lithium cell and a highly efficient relaxation oscillator encapsulated in epoxy and glass. A corkscrew electrode made from activated iridium can be screwed into the myocardium, followed by release of the pacemaker and a short, flexible lead entirely within the chest of the fetus to avoid dislodgement from fetal movement. The feasibility of implanting the device percutaneously under ultrasonic imaging guidance was demonstrated in acute adult rabbit experiments.

[1]  V. Aiello,et al.  Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred-Sixteen Cases From a Single Institution , 2008, Circulation.

[2]  S. Walkinshaw,et al.  In utero pacing for fetal congenital heart block. , 1994, Fetal diagnosis and therapy.

[3]  E. Rosenthal,et al.  Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. , 1995, Circulation.

[4]  G. Loeb,et al.  Parylene as a Chronically Stable, Reproducible Microelectrode Insulator , 1977, IEEE Transactions on Biomedical Engineering.

[5]  R J Carpenter,et al.  Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. , 1986, Journal of the American College of Cardiology.

[6]  John M. Simpson,et al.  Isolated Atrioventricular Block in the Fetus: A Retrospective, Multinational, Multicenter Study of 175 Patients , 2011, Circulation.

[7]  R H Anderson,et al.  Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. , 1986, The American journal of cardiology.

[8]  Mimi Y. Kim,et al.  Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study , 2008, Circulation.

[9]  E. Rosenthal,et al.  Outcome of isolated congenital complete heart block diagnosed in utero. , 1996, Heart.

[10]  Gerald E. Loeb,et al.  Design and Fabrication of an Injection Tool for Neuromuscular Microstimulators , 2009, Annals of Biomedical Engineering.

[11]  Perinatal Outcome of Fetal Complete Atrioventricular Block: A Multicenter Experience , 1991 .

[12]  D. Rurak,et al.  Chronic fetal and maternal instrumentation in pregnant sheep: effect on gestation length and birthweight. , 2010, Reproduction, fertility, and development.

[13]  F. Sherman,et al.  Use of terbutaline in the treatment of complete heart block in the fetus , 2001, Cardiology in the Young.

[14]  S. B. Brummer,et al.  Activated Ir: An Electrode Suitable for Reversible Charge Injection in Saline Solution , 1983 .

[15]  J. Westgate,et al.  Do Fetal Electrocardiogram PR-RR Changes Reflect Progressive Asphyxia after Repeated Umbilical Cord Occlusion in Fetal Sheep? , 1998, Pediatric Research.

[16]  A Tincani,et al.  Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. , 2010, Arthritis and rheumatism.

[17]  John M. Simpson,et al.  Isolated Atrioventricular Block in the Fetus , 2011 .

[18]  Roberto Costa,et al.  New lead for in utero pacing for fetal congenital heart block. , 2003, The Journal of thoracic and cardiovascular surgery.